Does THALIDOMIDE Cause Malignant neoplasm progression? 169 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 169 reports of Malignant neoplasm progression have been filed in association with THALIDOMIDE (Thalomid). This represents 1.0% of all adverse event reports for THALIDOMIDE.
169
Reports of Malignant neoplasm progression with THALIDOMIDE
1.0%
of all THALIDOMIDE reports
102
Deaths
24
Hospitalizations
How Dangerous Is Malignant neoplasm progression From THALIDOMIDE?
Of the 169 reports, 102 (60.4%) resulted in death, 24 (14.2%) required hospitalization, and 8 (4.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THALIDOMIDE. However, 169 reports have been filed with the FAERS database.
What Other Side Effects Does THALIDOMIDE Cause?
Plasma cell myeloma (1,652)
Off label use (1,356)
Death (1,161)
Neuropathy peripheral (1,068)
Drug ineffective (789)
Pneumonia (694)
Fatigue (643)
Constipation (461)
Thrombocytopenia (429)
Neutropenia (420)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which THALIDOMIDE Alternatives Have Lower Malignant neoplasm progression Risk?
THALIDOMIDE vs THALOMID
THALIDOMIDE vs THEOPHYLLINE
THALIDOMIDE vs THEOPHYLLINE ANHYDROUS
THALIDOMIDE vs THIAMINE
THALIDOMIDE vs THIOCOLCHICOSIDE